Predictive oncology inc. announces newest board member

Minneapolis, april 27, 2021 (globe newswire) -- predictive oncology (nasdaq: poai), a knowledge-driven company focused on applying artificial intelligence (“ai”) to personalized medicine and drug discovery, is excited to announce today their newest board member dr. christina jenkins.

POAI Ratings Summary

POAI Quant Ranking